Craig Hallum initiated coverage on shares of Strata Critical Medical (NASDAQ:SRTA – Free Report) in a research report report published on Wednesday morning, Marketbeat reports. The firm issued a buy rating and a $8.00 target price on the stock.
Separately, B. Riley Financial started coverage on Strata Critical Medical in a research note on Wednesday. They set a “buy” rating and a $8.00 target price on the stock. Two research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, Strata Critical Medical currently has an average rating of “Moderate Buy” and a consensus price target of $8.00.
Read Our Latest Analysis on SRTA
Strata Critical Medical Trading Up 1.9%
About Strata Critical Medical
Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.
Featured Articles
Receive News & Ratings for Strata Critical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Critical Medical and related companies with MarketBeat.com's FREE daily email newsletter.
